Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Total perfect manipulation (Repost)
"MY hope is that the event that triggers us is the USPTO validation when the street can't say this is too risky because the patents are under review."
I wrote this a year ago (in a dispute with Ron) and repeated it some months ago:
The main product of PTSC is its patents, thus the "product" needs to be finished BEFORE it goes to the market.
In this scenario the USPTO works like the last step of the "quality control": If they give their thumbs up, the PTSC product "patents" is ready for the market - with its full prize and without any question about validity or infringement by the companies, who have to pay.
Additionally I'm sure the settlement with the J3 will be another element of this "quality control" - IMO it will proof, that going to Court is NOT an alternative to paying.
GLTY
Share
New Message
Please login to post a reply